Professional Documents
Culture Documents
PDF Advances in Genetics 1St Edition Theodore Friedmann Ebook Full Chapter
PDF Advances in Genetics 1St Edition Theodore Friedmann Ebook Full Chapter
Theodore Friedmann
Visit to download the full and correct content document:
https://textbookfull.com/product/advances-in-genetics-1st-edition-theodore-friedmann/
More products digital (pdf, epub, mobi) instant
download maybe you interests ...
https://textbookfull.com/product/genetics-in-the-madhouse-the-
unknown-history-of-human-heredity-1st-edition-theodore-porter/
https://textbookfull.com/product/advanced-pharmacology-for-
prescribers-1st-edition-theodore-kendris/
https://textbookfull.com/product/peanuts-genetics-processing-and-
utilization-1st-edition-stalker/
https://textbookfull.com/product/computational-biology-a-
hypertextbook-1st-edition-scott-theodore-kelley/
Human Molecular Genetics 5th Edition Strachan
https://textbookfull.com/product/human-molecular-genetics-5th-
edition-strachan/
https://textbookfull.com/product/concepts-of-genetics-twelfth-
edition-cummings/
https://textbookfull.com/product/chemistry-the-central-
science-14th-edition-in-si-units-theodore-l-brown/
https://textbookfull.com/product/acetabular-fractures-in-older-
patients-assessment-and-management-theodore-t-manson/
https://textbookfull.com/product/ethical-legal-and-professional-
issues-in-counseling-5th-edition-theodore-p-remley-jr/
VOLUME NINETY THREE
ADVANCES IN
GENETICS
ADVANCES IN GENETICS, VOLUME 93
Serial Editors
Theodore Friedmann
Department of Pediatrics, University of California at San Diego,
School of Medicine, CA, USA
Jay C. Dunlap
Department of Genetics, The Geisel School of Medicine at Dartmouth,
Hanover, NH, USA
Stephen F. Goodwin
Department of Physiology, Anatomy and Genetics,
University of Oxford, Oxford, UK
VOLUME NINETY THREE
ADVANCES IN
GENETICS
Edited by
THEODORE FRIEDMANN
Department of Pediatrics, University of California
at San Diego, School of Medicine, CA, USA
JAY C. DUNLAP
Department of Genetics, The Geisel School
of Medicine at Dartmouth, Hanover, NH, USA
STEPHEN F. GOODWIN
Department of Physiology, Anatomy and Genetics,
University of Oxford, Oxford, UK
No part of this publication may be reproduced or transmitted in any form or by any means,
electronic or mechanical, including photocopying, recording, or any information storage and
retrieval system, without permission in writing from the publisher. Details on how to seek
permission, further information about the Publisher’s permissions policies and our
arrangements with organizations such as the Copyright Clearance Center and the Copyright
Licensing Agency, can be found at our website: www.elsevier.com/permissions.
This book and the individual contributions contained in it are protected under copyright by
the Publisher (other than as may be noted herein).
Notices
Knowledge and best practice in this field are constantly changing. As new research and
experience broaden our understanding, changes in research methods, professional practices,
or medical treatment may become necessary.
Practitioners and researchers must always rely on their own experience and knowledge in
evaluating and using any information, methods, compounds, or experiments described
herein. In using such information or methods they should be mindful of their own safety and
the safety of others, including parties for whom they have a professional responsibility.
To the fullest extent of the law, neither the Publisher nor the authors, contributors, or editors,
assume any liability for any injury and/or damage to persons or property as a matter of
products liability, negligence or otherwise, or from any use or operation of any methods,
products, instructions, or ideas contained in the material herein.
ISBN: 978-0-12-804801-6
ISSN: 0065-2660
E.E. Bezsonov
National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of
Health, Bethesda, MD, United States
H.K. Edskes
National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of
Health, Bethesda, MD, United States
T.R. Fenton
UCL Cancer Institute, University College London, London, United Kingdom
A. Gorkovskiy
National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of
Health, Bethesda, MD, United States
I.P. Hall
Division of Respiratory Medicine, University of Nottingham, Nottingham, United
Kingdom
Yi-Juan Hu
Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory
University, Atlanta, GA, United States
A.K. Kheirallah
Division of Respiratory Medicine, University of Nottingham, Nottingham, United
Kingdom
M. Lechner
Head and Neck Centre, University College London Hospital, London, UK; UCL Cancer
Institute, University College London, London, United Kingdom
S. Miller
Division of Respiratory Medicine, University of Nottingham, Nottingham, United
Kingdom
I. Sayers
Division of Respiratory Medicine, University of Nottingham, Nottingham, United
Kingdom
E.E. Stroobant
National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of
Health, Bethesda, MD, United States
Yan V. Sun
Department of Epidemiology, Rollins School of Public Health, Atlanta, GA, United States;
Department of Biomedical Informatics, School of Medicine, Atlanta, GA, United States
R.B. Wickner
National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of
Health, Bethesda, MD, United States
vii j
CHAPTER ONE
Contents
1. Introduction 2
1.1 The Role of Human Papillomavirus in Head and Neck Cancer 3
1.2 Human Papillomavirus-Driven Carcinogenesis 7
2. The Genome of Human Papillomavirus-Associated Head and Neck Cancer 12
2.1 Mutational Processes Shaping the HPVþ HNSCC Genome 13
2.2 Recurrent Mutations in HPVþ HNSCC and Considerations for Targeted Therapy 17
2.3 Copy Number Alterations and Translocations 19
3. The Epigenome of Human Papillomavirus-Associated Head and Neck Cancer 21
3.1 DNA Methylation of the Host Genome in HNSCC 22
3.2 Histone Covalent Modifications and Nucleosomal Remodeling in HPVþ 26
OPSCC
3.3 Epigenetic Modifications of the Viral Genome and Interactions With the Host 27
Genome and Epigenome
3.4 Causative Factors for Epigenetic Changes in HNSCC 28
3.5 Epigenetic Therapy 28
3.6 microRNAs in Head and Neck Cancer 29
4. The Transcriptome of Human Papillomavirus-Associated Head and Neck Cancer 30
4.1 Gene Expression Subtypes in HNSCC 30
4.2 Direct Comparisons of HPVþ and HPV HNSCC Transcriptomes 31
4.3 The Human Papillomavirus Transcriptome in HNSCC 33
4.4 Beyond the Transcriptome: Proteomic Studies of HPVþ HNSCC 34
5. Biomarker Development for Human Papillomavirus-Associated Oropharyngeal 35
Cancer
Abstract
Human papillomavirus (HPV) has been shown to represent a major independent
risk factor for head and neck squamous cell cancer, in particular for oropharyngeal
carcinoma. This type of cancer is rapidly evolving in the Western world, with rising
trends particularly in the young, and represents a distinct epidemiological, clinical,
and molecular entity. It is the aim of this review to give a detailed description of
genomic, epigenomic, transcriptomic, and posttranscriptional changes that underlie
the phenotype of this deadly disease. The review will also link these changes and
examine what is known about the interactions between the host genome and viral
genome, and investigate changes specific for the viral genome. These data are then
integrated into an updated model of HPV-induced head and neck carcinogenesis.
1. INTRODUCTION
Head and neck cancer is the sixth most common cancer worldwide
with an incidence of around 600,000 cases per annum, with rising trends
particularly in the young (Hunter, Parkinson, & Harrison, 2005;
Warnakulasuriya, 2009). Despite recent advances in the treatment and in
the understanding of its biology, the 5-year survival rate of 50% for patients
with head and neck cancer on the whole has remained largely unchanged for
the past three decades with relatively few advances since the 1990s (Conley,
2006). Head and neck squamous cell carcinomas (HNSCCs) account for
over 90% of head and neck cancers and are the focus of this review.
As an umbrella term, HNSCC includes cancers arising in mucosal
epithelia at several locations of the upper aerodigestive tract, eg, in the
oral cavity, pharynx, and larynx. Although these cancers have different
etiologies and prognoses, they share similar risk factors. These major risk
factors include the smoking and chewing of tobacco as well as alcohol
consumption (Hunter et al., 2005). Heavy smokers under the age of 46
have a 20-fold increased risk of oral and pharyngeal cancer, whereas heavy
drinkers are reported to have a 5-fold increased risk (Rodriguez et al., 2004).
A combination of heavy smoking and drinking leads to an almost 50-fold
increased risk of oral and pharyngeal cancer (Rodriguez et al., 2004).
OPSCC Genomics 3
parallel decline of HPV tumors. Taking into account the previously pre-
sented data, the incidence of HPV-positive tonsillar tumors has almost
doubled each decade between 1970 and 2007, suggesting an epidemic of
viral-induced carcinoma (Nasman et al., 2009).
HPV-related HNSCC occurs more frequently in younger patients (age
<50 years) with minimal tobacco and/or alcohol exposure but greater
exposure to oral sex, multiple sexual partners, or marijuana (Gillison et al.,
2008). Compared to HPV HNSCC patients, HPVþ HNSCC patients
are often of higher socioeconomic status with better nutrition, dentition,
and overall health compared to patients suffering from HPV disease.
Racial differences for HPV-related HNSCC have also been demonstrated.
In their study, Settle et al. (2009) found that 35% of Caucasian patients
developed HPVþ tumors compared with only 4% of patients of African
origin.
In summary, the epidemiological trend suggests that HPV-related
oropharyngeal squamous cell cancer is becoming more widespread at a
time when the overall incidence of HNSCC is falling and this subtype typi-
cally occurs in younger patients (age <50 years).
Moreover, this has major clinical implications. HPVþ HNSCC responds
better to chemotherapy and radiotherapy (82% vs 55% response rate for
HPV cases) and has a better disease-free and overall survival (95% vs
62% at 2 years) (Fakhry et al., 2008). Individuals with HPVþ HNSCC
have a lower rate of second primary tumors, as well as a decreased cumula-
tive incidence of relapse (Hafkamp et al., 2008; Licitra et al., 2006). Thus,
knowledge of a patient’s HPV status offers the possibility to stratify such
patients for treatment and to elucidate the mechanisms underlying the
virus-associated advantage in drug response and survival in HNSCC. A
summary of the distinct molecular, epidemiological, and clinical features is
provided in Table 1.
The causes responsible for the different clinical behaviors of HPVþ and
HPV tumors remain poorly understood. Aside from the differences in age
and overall health of patients noted above, molecular differences between
HPVþ and HPV HNSCCs, including mutational profiles and overall
mutation burden, intratumoral heterogeneity, epigenomic and transcrip-
tional profiles, and the infiltration of tumor-reactive lymphocytes may all
play a role in the differing clinical behavior of these tumors. This review
will focus on the considerable progress that has been made in the identifica-
tion of these molecular differences in the past few years and on the potential
for translation of this knowledge into improved outcomes for patients.
OPSCC Genomics
Table 1 Distinct molecular, epidemiological, and clinical features of HPVþ HNSCC, compared with HPV HNSCC
HPVþ HNSCC HPV HNSCC
Molecular factors TP53 wild type present in most cases TP53 mutational loss (disruptive) common
(if TP53 mutations are present, they are (Westra et al., 2008)
usually not disruptive (Westra et al., 2008)) CDKN2A(p16) underexpression (Jung
TP53 loss of function (rendered by the et al., 2010) or mutational loss (Jung et al.,
viral oncoprotein E6) (Mendenhall & 2010; Stransky et al., 2011)
Logan, 2009). No HPV DNA/RNA
RB1 loss of function (rendered by the viral
oncoprotein E7) (Doorbar, 2006)
CDKN2A(p16) overexpression (Jung
et al., 2010)
HPV DNA (type 16 in up to 85% of cases)
(D’Souza et al., 2007; Herrero et al., 2003;
Kreimer et al., 2005)
Possible epidemiological Often nonsmokers (D’Souza et al., 2007; Heavy smokers (D’Souza et al., 2007;
factors Gillison et al., 2008) Gillison et al., 2008)
Mild/moderate alcohol intake (D’Souza Heavy alcohol intake (D’Souza et al.,
et al., 2007; Gillison et al., 2008) 2007; Gillison et al., 2008)
High marijuana exposure (Gillison et al., Low marijuana exposure (Gillison et al.,
2008) 2008)
Intact dentition (Gillison et al., 2008) Poor dentition (Gillison et al., 2008)
High oral sex exposure (D’Souza et al., No Association with sexual behaviors
2007; Gillison et al., 2008) (D’Souza et al., 2007; Gillison et al., 2008)
(Continued)
5
Table 1 Distinct molecular, epidemiological, and clinical features of HPVþ HNSCC, compared with HPV HNSCCdcont'd
6
HPVþ HNSCC HPV HNSCC
Younger age (<45 years) (Chaturvedi, Older age (>50 years) (Chaturvedi et al.,
Engels, Anderson, & Gillison, 2008; 2008; Chaturvedi et al., 2011)
Chaturvedi et al., 2011) Decreasing incidence of the disease (Marur
Increasing incidence of the disease (Marur, et al., 2010; Nasman et al., 2009)
D’Souza, Westra, & Forastiere, 2010;
Nasman et al., 2009)
Histopathological Frequently basaloid, nonkeratinizing, Frequently keratinizing SCC (Mendelsohn
appearances poorly differentiated SCC (Mendelsohn et al., 2010)
et al., 2010)
Clinical factors Predominantly oropharynx (tonsil and All head and neck sites (D’Souza et al.,
tongue base) (D’Souza et al., 2007; 2007; Mendenhall & Logan, 2009; Tran
Mendenhall & Logan, 2009; Tran et al., et al., 2007)
2007) Worse survival (Ang et al., 2010; Fakhry
Better survival (Ang et al., 2010; Fakhry et al., 2008)
et al., 2008) Radiation response unpredictable (Fakhry
More radiosensitive (Fakhry et al., 2008) et al., 2008)
Higher rates of patients presenting with
nodal metastases and SCC of unknown
primary (Jensen et al., 2014; Mendelsohn
Figure 1 HPV16 genome organization and life cycle. (A) The prototypical HPV16
genome showing the viral oncogenes (E6 and E7, also known as accessory genes, since
they are not found in all papillomaviruses) in red (gray in print versions), the genes
required for viral genome replication and amplification (E1, E2, E4, and E5) in yellow
(light gray in print versions) and the capsid genes (L1 and L2) in green (dark gray in
print versions). The long control region is shown upstream of the p97 promoter,
from which the bicistronic E6/E7 transcript is expressed. E1eE5 are expressed from
the p670 promoter, which also drives expression of L1 and L2 following activation of
alternative splicing in the upper layers of the epithelium. Lollypops represent sites of
OPSCC Genomics 9
of both cellular and viral DNA by the host DNA polymerase machinery. As
cells move up from the basal layer and begin to differentiate, E6/E7 expres-
sion decreases and the remaining early genes (E1, E2, E4, and E5) are tran-
scribed from a second promoter. These genes drive viral genome
amplification to greater than 1000 copies per cell. Finally, as cells reach ter-
minal differentiation in the uppermost layer the capsid proteins (L1 and L2)
are expressed and progeny virions are assembled. These virions are then
released as the host cells die (Fig. 1B, also see (Doorbar et al., 2012; Egawa
et al., 2015) and references therein for further detail).
Doorbar and colleagues have proposed that problems occur when high-
risk HPVs infect cells with two key characteristics. Firstly, stem, or stemlike
cells (such as cervical reserve cells), in which the virus can persist with min-
imal viral gene expression for many years without the host cell entering into
epithelial differentiationda state increasingly recognized as HPV latency
(Doorbar, 2013). Secondly, cells in which the correct regulation of viral
gene expression does not occur, and therefore a productive viral life cycle
is not supported. In the oropharynx, the reticulated epithelium of the
tonsillar crypts may represent such a subsite, with the additional consider-
ation that virally infected stem cells may escape surveillance in this in this
=---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
CpG methylation that have been detected in tumor cells (see Section 3.3). (B) Schematic
representation of a productive HPV16 infection in the tonsillar crypt. (1) Viral entry to
the basal layer may be facilitated by the reticulated nature of the stratified epithelium
at this subsite. (2) Upon entry into the nuclei of basal progenitor cells, E6 and E7 are
expressed, causing cell cycle entry and cell division in the basal layer. (3) As cells
move up through the epithelium and begin to differentiate, E1, E2, E4, and E5 are
expressed from the p670 promoter and viral genome amplification occurs. (4) Alterna-
tive splicing in the terminally differentiated cells of the upper squamous epithelium
produces the L1 and L2 capsid proteins, allowing viral packaging and shedding of virus
as the differentiated keratinocytes die and slough away from the epithelium. (C) Rep-
resentation of an invasive SCC in the tonsillar crypt epithelium. Regulation of viral gene
expression has been lost, resulting in constitutive, high-level E6/E7 production, inhibi-
tion of differentiation and extensive proliferation of cells throughout the epithelium.
Additional alterations to the host genome and epigenome cooperate to generate an
invasive, metastatic phenotype. The tumor has invaded through the basement mem-
brane into the lymphoid tissue below and tumor infiltrating lymphocytes are evident
in the tumor mass. Figure adapted from Doorbar, J., Quint, W., Banks, L., Bravo, I.G.,
Stoler, M., Broker, T.R., & Stanley, M. A. (2012). The biology and life-cycle of human pap-
illomaviruses. Vaccine, 30(Suppl. 5), F55eF70. http://dx.doi.org/10.1016/j.vaccine.2012.06.
083. and Egawa, N., Egawa, K., Griffin, H., & Doorbar, J. (2015). Human papillomaviruses;
epithelial tropisms, and the development of neoplasia. Viruses, 7(7), 2802. Retrieved from:
http://www.mdpi.com/1999-4915/7/7/2802 with kind permission from Dr. John Doorbar.
10 M. Lechner and T.R. Fenton
(hTERT), and the closely related transcriptional coactivators p300 and CREB
binding protein (EP300 and CREBBP) (Leemans et al., 2011; Mesri et al.,
2014; Pim & Banks, 2010). Through their interactions with these and other
targets (for a detailed review see (Pim & Banks, 2010)), E6 and E7 therefore
set the stage for cellular transformation and to a large extent, likely dictate the
additional genetic and epigenetic alterations that are necessary for the devel-
opment of invasive carcinoma. Recent large-scale -omics studies have begun
to reveal some of the most common somatic events seen in HPVþ HNSCC
and these will be discussed in detail in Sections 2 and 3.
Integration of viral genes is frequently observed in HPV-associated cancers
(Kim et al., 2007; Parfenov et al., 2014; Schmitz, Driesch, Jansen, Runne-
baum, & Durst, 2012). The E2 gene, which functions in HPV genome repli-
cation and normally acts as a repressor of E6 and E7 transcription, is often
disrupted upon integration. Complete loss of E2 expression occurs following
the clearance of remaining episomes and results in a significant increase in E6/
E7 expression in cervical keratinocytes undergoing HPV-driven transforma-
tion in culture (Pett et al., 2006). The overlapping E5 gene is also commonly
lost from integrants, and as such is not regarded as being a mediator in late
stage carcinogenesis, although it may play important roles in the initiation
of cellular transformation (see Section 4.3 (Schwarz et al., 1985)). Mapping
of HPV integration sites by whole-genome sequencing (WGS) in HPVþ
HNSCC revealed a bias toward genic regions, frequently associated with dis-
rupted expression and/or rearrangements of host genes, suggesting this may
be a contributing factor in the development of these tumors (Parfenov
et al., 2014). Integration-independent transformation of HPV-infected kera-
tinocytes has been observed in culture, however, and in The Cancer Genome
Atlas (TCGA) WGS study, 10 of 35 HPVþ HNSCCs showed no evidence of
integration, thus integration is not a requirement for HPV-associated tumor
development (Gray et al., 2010). Interestingly, HNSCCs with integrated
HPV and those without integration display distinct gene expression profiles
and DNA methylation patterns, suggesting they may arise via subtly different
mechanisms and may potentially display vulnerabilities to different therapeu-
tic approaches (Parfenov et al., 2014).
15
Henderson, S., Chakravarthy, A., Su, X., Boshoff, C., & Fenton, T.R. (2014). APOBEC-mediated cytosine deamination links PIK3CA helical domain
mutations to human papillomavirus-driven tumor development. Cell Reports, 7(6), 1833e1841. http://dx.doi.org/10.1016/j.celrep.2014.05.012.
16 M. Lechner and T.R. Fenton
prominent in carcinomas of the bladder, cervix, head and neck, breast, and
lung (Alexandrov, Nik-Zainal, Wedge, Aparicio, et al., 2013; Burns,
Lackey, et al., 2013; Burns, Temiz, & Harris, 2013; Roberts et al.,
2013). Several A3 (A3AeD, F, G, H) enzymes function in innate
immunity, creating C > U mutations in single-stranded viral DNA. The
restriction of HIV infectivity by A3G in T-lymphocytes is the best-studied
example of this but HPV DNA is also targeted by A3s and recent data
suggest A3A could function as an HPV restriction factor (Vartanian,
Guetard, Henry, & Wain-Hobson, 2008; Warren et al., 2015). Stratifica-
tion of the TCGA HNSCC data set by HPV status based on detection
of RNA-seq reads corresponding to viral transcripts revealed increased
expression of A3B and strong enrichment for the APOBEC mutational
signature in the HPVþ tumors (Fig. 3 (Henderson et al., 2014)). As
discussed above, the PI3K pathway is subject to recurrent mutational
activation in HNSCC. In particular, PIK3CA, which encodes the catalytic
PI3K isoform, p110a, is mutated and/or amplified in over 50% of HPVþ
HNSCC (The Cancer Genome Atlas, 2015). Strikingly, PIK3CA
mutations in HPVþ HNSCC almost invariably occur at one of two
hotspots in the helical domain, which is responsible for the interaction
with the p85 adapter subunit. These glutamate to lysine mutations
(E542K and E545K) both result from C:G > T:A transitions within
optimal (TpCpA) motifs for cytosine deamination by A3. In HPV
HNSCC, PIK3CA mutation is also frequent but often these mutations
are at a second hotspot (H1047) in the kinase domaindthese are typically
A:T > G:C transitions, unrelated to cytosine deamination (Henderson
et al., 2014). The correlation between A3 signature mutations and helical
versus kinase domain PIK3CA mutations across multiple cancer types and
the occurrence of these mutations coincident with appearance of the A3
signature in lung cancer subclones during tumor evolution both strongly
suggest that PIK3CA helical domain mutations are caused by A3 activity
(de Bruin et al., 2014; Henderson et al., 2014). These findings, confirmed
by TCGA’s own analysis of the data and supported by studies showing that
A3B is induced by E6 in keratinocytes following HPV infection, suggest a
model in which HPV oncogene expression not only creates genomic
instability but also acts in a hitherto unanticipated fashion to drive somatic
mutagenesis of key protooncogenes by triggering APOBEC activity
((Henderson et al., 2014; The Cancer Genome Atlas, 2015; Vieira et al.,
2014; Warren et al., 2015) reviewed in (Henderson & Fenton, 2015)).
OPSCC Genomics 17
HPV oncoproteins with the genomic and epigenomic data, we will be able
to predict specific vulnerabilities that may represent therapeutic targets in
these tumors. With this in mind, as research into HPVþ HNSCC moves
forward, it is essential that we continue to complement tumor “omics”
studies with a detailed examination of E6 and E7 biology.
Mining
Investments
Paraguay has been called the most romantic of all the South
American countries, from the point of view of nature and history both.
It is a land of “dolce far niente” so far as agreeableness is
concerned, a land where nature is lavish and necessities are few; on
the other hand a region where the climate is not enervating, where
energetic action and enterprise are not altogether lacking, and where
these find ample reward. One of the two inland countries of the
continent, having always been such, she has no grievance on this
account. In fact, being in the heart of South America and almost
surrounded by rivers, Paraguay has in many ways a most favorable
location for inland commerce, which will surely bring her prosperity.
History
Government
Population
The Paraguayans claim that their people are nearly pure Spanish,
with slight admixture of Guaraní, this being the most numerous,
intelligent, and peaceful of the Indian tribes of that region. Preserving
the spirit of the invaders, they are an unusually hardy race for one on
the edge of the tropics. While Spanish blood and culture largely
predominate in the capital, the population of the rural districts is
more primitive in character.
The number of the people is uncertain, but may reach 1,000,000,
including 50,000, some say 100,000 wild Indians belonging to
several tribes, chiefly in the Chaco. In the eastern section of
Paraguay proper there are probably not over 25,000 persons, most
of the population being east and south of the mountainous section
and especially near the Paraguay River. They say that there are no
idle or poor in the country, although many may be seen barefoot in
Asunción; as the simple life is popular, little clothing is needed, and
food is abundant. (Of late the standard of living has been rising.) For
this reason the country people generally lack energy and ambition.
Most of the inhabitants are engaged in agriculture, some also in
pastoral pursuits. The native women are called superior to the men.
Burdens thrown upon them during their great war made them
resourceful and independent. The men as a rule are peaceful unless
they have been drinking caña, which is now forbidden by some large
employers of labor. In the section east of the mountains are
uncivilized Indians of the principal tribes, one timid and retiring.
Some of the Cainguaes at times work in the yerbales. The Indians in
the Chaco are of a number of different tribes of a low order of
civilization, who are mostly nomads, and live by the chase and
fishing. A few work at estancias spasmodically, never for long.
Education
Climate
The Capital
Other Cities
Transportation